drugset / Trial / NCT00338052

Study of Bleeding With Extended Administration of an Oral Contraceptive

NCT00338052

Phase 2 Completed 207 enrolled Warner Chilcott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.

Timeline

Start
2006-06
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Norethindrone Unknown 1 mg Oral
Subject ethinyl estradiol Small molecule 20 ug Oral

Indications

No indication recorded.